GlassScriptPhysician profile
Amanda Francis
NPI 1679833727
$530.28
in general payments reported to CMS, 2019-2025
13 companies · $57.56 in 2025
The $57.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.39 · 2020: $149 · 2021: $33.09 · 2022: $239 · 2025: $57.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $108.40 | 2020-2022 | |
| Medtronic, INC. | $85.47 | 2022 | |
| Daiichi Sankyo INC. | $84.46 | 2019-2022 | |
| Astellas Pharma US INC | $41.06 | 2025 | Veozah |
| Therapeuticsmd, INC. | $41.03 | 2019-2020 | |
| Alydia Health | $33.09 | 2021 | |
| Exeltis, USA INC. | $30.34 | 2020-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $25.38 | 2022 | |
| Millicent US INC | $24.89 | 2019-2020 | |
| Myovant Sciences INC. | $15.52 | 2022 | |
| Evofem Biosciences, INC. | $14.99 | 2022 | |
| Avion Pharmaceuticals | $14.19 | 2020 | |
| Minerva Surgical, INC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.